ask="56.02"
ask_size="100"
average_daily_volume="1099270"
bid="37.50"
bid_size="100"
book_value="3.62"
change="+0.70"
change_from_200_day_moving_average="-3.02"
change_from_50_day_moving_average="1.42"
change_from_52_week_high="-12.00"
change_From_52_week_low="10.97"
change_in_percent="+1.65%"
close="43.15"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-146.03M"
eps_estimate_current_year="-2.13"
eps_estimate_next_quarter="-0.62"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="85681000"
high="43.63"
high_52_weeks="55.15"
last_trade_date="2/16/2017"
last_trade_price="43.15"
last_trade_size="95597"
last_trade_time="4:00pm"
low="42.39"
low_52_weeks="32.18"
market_capitalization="3.75B"
moving_average_200_day="46.17"
moving_average_50_day="41.73"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.58"
open="42.60"
pe_ratio="N/A"
peg_ratio="0.54"
percent_change_from_200_day_moving_average="-6.54%"
percent_change_from_50_day_moving_average="+3.41%"
percent_change_from_52_week_high="-21.76%"
percent_change_from_52_week_low="+34.09%"
previous_close="42.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.71"
price_per_sales="245.85"
revenue="15.00M"
shares_outstanding="86874000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="926588"
weeks_range_52="32.18 - 55.15"
